Article

Long-term endothelial changes in phakic eyes with posterior chamber intraocular lenses.

Department of Ophthalmology, University of Vienna Medical School, Vienna, Austria.
Journal of Cataract and Refractive Surgery (Impact Factor: 2.53). 10/2002; 28(9):1589-93. DOI: 10.1016/S0886-3350(02)01210-5
Source: PubMed

ABSTRACT To evaluate the long-term endothelial cell changes in phakic eyes after implantation of a posterior chamber phakic intraocular lens to correct high ametropia.
Department of Ophthalmology, University Hospital of Vienna, Vienna, Austria.
Thirty-four eyes of 21 patients having implantation of an implantable contact lens (ICL, Staar Surgical) for high myopia or hyperopia were prospectively examined. The minimum follow-up was 2 to 4 years. Preoperative and serial postoperative specular microscopy (Noncon Robo SP 8000, Konan) was performed to evaluate the long-term endothelial cell changes.
The mean preoperative endothelial cell density was 2854 cells/mm(2). The mean endothelial cell loss from preoperatively was 1.8% at 3 months, 4.2% at 6 months, 5.5% at 12 months, 7.9% at 2 years (n = 34), 12.9% at 3 years (n = 13), and 12.3% at 4 years (n = 11). All other endothelial cell characteristics remained stable during the 4-year follow-up.
Continuous endothelial cell loss was observed after ICL implantation during a 4-year follow-up. There was rapid cell loss until 1 year postoperatively, after which the rate of loss was no longer statistically significant. The percentage of hexagonal cells (polymorphism) and the coefficient of variation (polymegethism) remained stable during the 4-year follow-up.

0 Bookmarks
 · 
123 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Die optische Qualität nach Korrektur höherer Fehlsichtigkeiten mittels phaker Intraokularlinsen (PIOL) ist im Vergleich zu korneal-ablativen Verfahren potenziell besser, da die normale prolate korneale Asphärizität bei akzeptabler effektiver optischer Zone erhalten bleibt. Verbesserungen des Materials und Designs phaker IOL, der Implantationsinstrumente sowie eine bessere Kenntnis der Interaktion der PIOL mit den umliegenden anatomischen Strukturen führten in den letzten Jahren zu einer gestiegenen Sicherheit und Akzeptanz. Klinische Studien zu PIOL zeigten eine gute Vorhersagbarkeit, Stabilität und Effektivität. Die Sicherheit dieser Implantate über einen längeren Zeitraum (>5 Jahre) hingegen wurde bislang nicht belegt, auch wenn die Implantation PIOL bereits jetzt von vielen Ophthalmochirurgen unter diversen Umständen als das refraktiv-chirurgische Verfahren der Wahl angesehen wird. In dieser Übersicht wird auf die Vor- und Nachteile der verschiedenen aktuellen PIOL-Typen sowie deren Komplikationen eingegangen. Es ist davon auszugehen, dass Verfeinerungen der Bildgebung zu einer genaueren PIOL-Größenbestimmung (besonders in Hinblick auf die ICL) führen werden. Eine recht präzise Vorhersage der effektiven postoperativen Linsenposition mit geringer Abweichung von der Zielrefraktion wäre somit möglich. Die Patienten sollten wissen, dass die Implantation einer phaken Intraokularlinse die Fehlsichtigkeit weitestgehend ausgleicht, aber sowohl die zugrunde liegende Pathologie als auch die Änderungen durch die Operation zu ernsten Komplikationen führen können.
    Der Ophthalmologe 01/2004; 101(3). · 0.53 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Purpose To assess the safety and efficacy of the implantable contact lens (ICL™) to treat myopia. Design Clinical, retrospective, single center, non-randomized case series. Participants Sixty-nine eyes of 46 patients with myopia ranging from −3.00 to 25.00 D were included in this study. Intervention Implantation of the ICL™. Main outcome measures Uncorrected Visual Acuity (UCVA), refraction, best spectacle corrected visual acuity (BSCVA), adverse events, operative and postoperative complications, subjective assessment and symptoms. Results The mean follow-up was 12.35 ± 6.13 (SD) months (range, 6 months–32 months). At the last visit, 49.20% of eyes had 20/20 or better UCVA compared to preoperative 20/20 or better BSCVA of 31.9% of eyes; 69.23% of eyes had postoperative UCVA better than or equal to preoperative BSCVA. The mean manifest refractive cylinder was 1.93 ± 1.21 D at baseline and 1.00 ± 0.92 D postoperatively. The mean manifest refraction spherical equivalent (MRSE) was −11.70 ± 4.24 D preoperatively and −0.69 ± 1.13 D postoperatively. A total of 69.8% of eyes were within ±0.5 D of the predicted MRSE; 84.1% were within ±1.0 D, and 88.90% were within ±2.0 D. BSCVA of 20/20 or better was achieved in 64.6% of eyes postoperatively, compared to 31.9% preoperatively. Mean improvement in BSCVA was 1line. One eye (1.5%) lost ⩾2 lines of BSCVA at the last visit, whereas 20% of eyes improved by ⩾2 lines. A total of 56.92% of cases gained ⩾1 line of BSCVA and 4.62% of cases lost ⩾1 line. Four ICL lenses were removed without significant loss of BSCVA, and 2 eyes with clinically significant lens opacities were observed. Four eyes (5.8%) developed a pupillary block the first day postoperatively. One eye (1.4%) developed a hypotony and AC shallowing. Conclusion Implantation of ICL for the correction of myopia was a safe procedure with good visual and refractive results from the early postoperative period to 1 year. Long-term follow-up is required to confirm the long-term safety of this implant.
    Saudi Journal of Ophthalmology 10/2013; 27(4):259–266.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Many factors are involved in choosing which approach is best for each patient. By Mayank a. nanavaty, DO, MRCS(ED), FRCOphth; and Sheraz M. Daya, MD, FACp, FACS, FRCS(ED), FRCOphth decision-Making: rLe versus phakic ioLs Refractive lens exchange (RLE) and phakic IOL implantation are alternative options to laser ablative refractive surgery. As intraocular procedures, both carry the very low but real risk of endophthalmitis. This risk has been reduced considerably by the incorporation of intraocular cefuroxime into current practice in Europe. 1 Although rare, potential complications including retinal detachment and cystoid macular edema must be considered and discussed with a patient in detail before surgery. UnderStanding RLE and Phakic iOLS RLE is safe and effective for the correction of moderate to severe myopia 2-7 and hyperopia. 8-13 Monofocal, toric, multifo-cal, and accommodating IOLs are available options that can be chosen based on patient needs and expectations. The safety of the procedure has been enhanced by the introduction of microincision cataract surgery (MICS) and of lenses that can be inserted through 1.8-mm incisions. Because RLE causes loss of accommodation, the procedure should be avoided if a patient's natural lens is still functional. 14-18 Several available multifocal IOLs provide patients with increased depth of focus including near, intermediate, and distance vision and make RLE an attractive option for both patient and surgeon. The primary advantages of phakic IOLs are rapid visual recovery, reversibility, a broader range of treatable ametropia, high predictability rates, stability, and preservation of accommodation. 19-27
    10/2012;